Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Karyopharm Therapeut
(NQ:
KPTI
)
9.710
USD
+0.020 (+0.21%)
Official Closing Price
Updated: 5:54 PM EDT, Apr 16, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,403,048
Open
9.660
Bid (Size)
9.610 (3)
Ask (Size)
9.710 (10)
Prev. Close
9.690
Today's Range
9.530 - 9.950
52wk Range
9.530 - 25.98
Shares Outstanding
74,634,291
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Antengene Announces NMPA Approval of IND Application for ATG-019 in Patients with Advanced Solid Tumors or Non-Hodgkin's Lymphoma
April 05, 2021
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in...
From
PR Newswire
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2021
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Compensation Committee of Karyopharm's Board of...
From
PR Newswire
Performance
YTD
-42.61%
-42.61%
1 Month
-22.38%
-22.38%
3 Month
-36.62%
-36.62%
6 Month
-38.11%
-38.11%
1 Year
-53.00%
-53.00%
More News
Read More
Karyopharm Receives Conditional Marketing Authorization from the European Commission for NEXPOVIO® (selinexor) in Combination with Dexamethasone for the Treatment of Adult Patients with Relapsed and o
March 29, 2021
From
PR Newswire
Karyopharm Stock Is Trading Higher After China's NMPA Signs Off Early-Stage ATG-019 Study In Cancer Settings
April 06, 2021
Tags
Health Care
General
FDA
From
Benzinga
Expanded Partnership with Medidata Supports Karyopharm’s Mission to Develop First-in-Class Therapeutics
March 10, 2021
From
Business Wire News Releases
Karyopharm's Selinexor Receives Conditional Approval In Europe For Type Of Blood Cancer
March 29, 2021
Tags
News
Biotech
Health Care
From
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 29, 2021
Tags
KPTI
Movers
HYMC
From
Benzinga
Interesting KPTI Put And Call Options For November 19th
March 19, 2021
Tags
Stocks
From
Market News Video
Stocks That Hit 52-Week Lows On Wednesday
March 03, 2021
Tags
Benzinga
ATNX
KPTI
From
Benzinga
Stocks That Hit 52-Week Lows On Friday
Today 13:00 EDT
Tags
JUPW
ALNA
MNOV
From
Benzinga
The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead
April 14, 2021
Tags
ZYME
SRPT
MLND
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.